ACTM-838, a novel systemically delivered bacterial immunotherapy that enriches in solid tumors and delivers IL-15/IL-15Rα and STING payloads to engage innate and adaptive immunity in the TME and enable a durable anti-tumor immune response.
期刊:Oncotarget
影响因子:0.000
doi:10.18632/oncotarget.28769
Cron Kyle R, Fang Ping, Pham Oanh, Janes Julie, Brandenburg John, Lu William, Zhu Jonathan, Peterson Bret, Tribble Sara, Kehoe Haixing, Makarova Anastasia, Iannello Alex, Chan Jean, Skoble Justin, He Hailey, Rae Chris, Thanos Christopher D, Udyavar Akshata R